ClearPoint Neuro
CLPT
50 hedge funds and large institutions have $45.4M invested in ClearPoint Neuro in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 28 closing their positions.
760% more call options, than puts
Call options by funds: $2.44M | Put options by funds: $284K
5.38% less ownership
Funds ownership: 20.07% → 14.69% (-5.4%)
8% less capital invested
Capital invested by funds: $49.5M → $45.4M (-$4.05M)
22% less funds holding
Funds holding: 64 → 50 (-14)
38% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 16
46% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
+$2.06M |
| 2 |
Millennium Management
New York
|
+$1.95M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.08M |
| 4 |
E
Ergoteles
New York
|
+$935K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$898K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$8.91M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.53M |
| 3 |
Renaissance Technologies
New York
|
-$1.61M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.47M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.35M |
CLPT Hedge Fund Activity: Q2 2022 in Review
50 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2022, worth a combined $45.4M — down 8.2% from $49.5M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CLPT and 15 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 10 added.
The largest buyer was Brown Advisory, adding an estimated $2.06M. The largest seller was BlackRock, cutting an estimated $8.91M.
- 50 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2022, down from 64 in Q1 2022.
- Funds reported $45.4M of ClearPoint Neuro stock for Q2 2022, down 8.2% quarter-over-quarter.
- 15 funds opened new ClearPoint Neuro positions in Q2 2022 and 28 closed out, a net change of -13 holders.
- The largest ClearPoint Neuro buyer in Q2 2022 was Brown Advisory, an estimated $2.06M added.
- The largest ClearPoint Neuro seller in Q2 2022 was BlackRock, an estimated $8.91M sold.
Based on aggregated 13F filings for Q2 2022.